文献速递膀胱癌与上尿路尿路上皮癌

北美和欧洲选定中心机器人辅助与开放根治性膀胱切除术使用趋势差异及围手术期结局随时间变化:一项国际多中心合作研究

Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration.
PubMed 文献 · BJU Int · 2019-06-02

该回顾性研究纳入2006—2018年北美和欧洲12个中心2401例接受开放根治性膀胱切除术(ORC)或机器人辅助根治性膀胱切除术(RARC)的膀胱癌患者,比较RARC与ORC使用趋势及围手术期结局变化。结果显示RARC使用比例从2006—2008年的29%升至2015—2018年的54%,在北美中心自2006年起即高于ORC且保持稳定,在欧洲中心则从2%指数增长至50%。

要点

  • RARC总体占49.5%,ORC占51.5%,RARC在近期患者中成为最常用术式。
  • RARC使用比例从2006—2008年29%升至2015—2018年54%(P < 0.001)。
  • 北美中心RARC自2006年起使用高于ORC且稳定,欧洲中心从2%增至50%。

核心结论

  • RARC自引入以来使用持续增加,在最近系列中超过ORC。
  • 北美中心RARC自引入起即较ORC更常用且使用基本稳定,欧洲中心则呈指数增长。
  • 北美与欧洲中心RARC/ORC使用趋势及围手术期结局随时间变化的差异可归因于前者较后者更早引入和推广RARC。

研究设计与样本

  • 回顾性评估2006年至2018年间北美和欧洲12个中心2401例接受ORC或RARC治疗的膀胱癌患者。
  • 采用Kruskal-Wallis检验和卡方检验评估连续变量和分类变量间的差异。

主要发现

  • 总体49.5%患者接受RARC,51.5%接受ORC。
  • RARC使用比例从2006—2008年29%增至2015—2018年54%(P < 0.001)。
  • 北美中心RARC使用自2006年起高于ORC并随时间保持稳定,欧洲中心RARC使用从2%指数增长至50%。
  • 两组中接受RARC的患者T分期更早(P < 0.001)、美国麻醉医师协会评分更低(P < 0.05)、出血量更少(P = 0.001)、住院时间更短(P < 0.05)。
  • 早期并发症无差异;欧洲中心接受RARC的患者早期再入院和再手术率更差,但仅考虑近期患者时统计学显著性消失。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare trends in the use of robot-assisted radical cystectomy (RARC) and changes over time in peri-operative outcomes in selected North American and European centres. MATERIALS AND METHODS: We conducted a retrospective evaluation of 2401 patients treated with open radical cystectomy (ORC) or RARC for bladder cancer at 12 centres in North America and Europe between 2006 and 2018. We used the Kruskal-Wallis and chi-squared test to evaluate differences between continuous and categorical variables. RESULTS: Overall, 49.5% of patients underwent RARC and 51.5% ORC. RARC became the most commonly performed procedure in contemporary patients, with an increase from 29% in 2006-2008 to 54% in 2015-2018 (P < 0.001). In the North American centres the use of RARC was higher than that of ORC from 2006, and remained stable over time, whereas in the European centres its use increased exponentially from 2% to 50%. In both groups patients who underwent RARC had less advanced T stages (P < 0.001), lower American Society of Anesthesiologists scores (P < 0.05), lower blood loss (P = 0.001) and shorter length of hospital stay (P < 0.05). No differences were found in early complications. Early readmission and re-operation rates were worse for patients treated with RARC in the European centres; however, when contemporary patients only were considered, the statistical significance was lost. CONCLUSION: The present study shows that the use of RARC has constantly increased since its introduction, overtaking ORC in the most contemporary series. While RARC was more frequently performed than ORC since its introduction in the North American centres and its use remained substantially stable over time, its use increased exponentially in the European centres. The different trends in use of RARC/ORC and changes over time in peri-operative outcomes between the North American and European centres can be attributed to the earlier introduction and spread of RARC in the former compared with the latter.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Zamboni S, Soria F, Mathieu R, et al. Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration. BJU Int. 2019. PMID: 31055865. doi:10.1111/bju.14791

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。